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Changing Epidemiology of Nosocomial Bloodstream Infections in 
11 Teaching Hospitals in Taiwan Between 1993 and 2006
Chia-Ying Liua,b, Chun-Hsing Liaoa, Yee-Chun Chenb, Shan-Chwen Changb*
aDepartment of Internal Medicine, Far-Eastern Memorial Hospital, Taipei, Taiwan.
bSection of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
BACKGROUND/PURPOSE: Healthcare-associated infections, formerly known as nosocomial infec-
tions, are one of the most important issues in current practice. Understanding trends in overall infection 
rates, as well as their incidence and proportion among different causative organisms, can help us to better 
define our infection control methods and therapy goals. To understand the changing epidemiology of 
nosocomial bloodstream infections (BSI) in Taiwan, we retrospectively collected nosocomial infection 
data from 11 hospitals and examined the trends and changing patterns of nosocomial BSI.
METHODS: Eleven major teaching hospitals in Taiwan were invited to participate in the study. The over-
all density of nosocomial infections and major BSI-causing organisms, including Staphylococcus aureus, 
Pseudomonas aeruginosa, Acinetobacter baumannii, and Candida species, were collected. The distribution of 
the different Candida species was also recorded. Background parameters from the 11 hospitals, including 
the size of the hospital, hospital capacity, the number of blood stream infection events, and average length 
of stay, were also recorded.
RESULTS: The incidence of nosocomial BSI ranged 0.23–2.56 per 1,000 patient-days, which accounted 
for 8–43% of all nosocomial infections. The most common causative organism of nosocomial bacteremia 
was S. aureus, ranging 0.88–0.01 per 1,000 patient-days. Overall, the incidence of S. aureus bacteremia has 
decreased over the last 13 years, but this difference was not statistically significant (p = 0.053). The rate of 
Candida fungemia (p < 0.01) and A. baumannii (p = 0.03) bacteremia increased significantly. C. albicans 
accounted for most cases of nosocomial fungemia, ranging from 40% to 80%, followed by Candida tropicalis, 
Candida parapsilosis and Candida glabrata. However, the incidence varied significantly from hospital to hospital, 
and the highest incidence was observed in a cancer center.
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Introduction
Healthcare-associated infections (HAI) are the most com-
mon complications in hospitalized patients and can re-
sult in increased mortality, length of stay and cost.1 HAI, 
mainly comprising ventilator-associated pneumonia, 
catheter-related urinary tract infections, bloodstream in-
fections (BSI) and surgical site infections, affect between 
5–10% of patients admitted to acute care hospitals.1 Thus, 
regular surveillance of HAI and the establishment of ap-
propriate infection control policies should be given high 
priority in modern medical care. Several infection control 
surveillance programs had been set up around the world, 
e.g. the National Healthcare Safety Network (NHSN) in 
20052–4 and the former National Nosocomial Infections 
Surveillance System (NNIS) in 1970 in the Unites States;5,6 
the International Nosocomial Infection Control Consor-
tium in developing countries in Latin America, Asia, Africa 
and Europe;7–9 the Infection Surveillance and Control 
Programs in Korea in 1991;10,11 the German national NI 
Surveillance system (Krankenhaus Infektions Surveillance 
System) in Germany;12 and similar programs in France 
and England.13–15
Regular surveillance of nosocomial infections can 
help healthcare workers to monitor the incidence of noso-
comial infections and the common causative organisms, 
which can guide infection control measurement and the 
appropriate use of antimicrobial agents. In particular, no-
socomial BSI, including bacteremia and fungemia, are 
associated with high mortality and morbidity despite an-
tibiotic treatment. However, accurate epidemiological in-
formation regarding nosocomial BSI in Taiwan is scarce.16,17 
The only report of BSI at a single university hospital col-
lected from 1996 to 2003 showed a predominance of aerobic 
Gram-negative bacilli.17 Understanding trends in overall 
infection rates and the incidence and proportion of differ-
ent causative organisms can help us to guide the direction 
of infection control. To understand the changing epide-
miology of nosocomial BSI in Taiwan, we retrospectively 
collected the nosocomial infection data from 11 major 
hospitals and examined the trends and changing patterns 
of nosocomial BSI from 1993 to 2006.
Methods
Population and hospitals
Eleven major hospitals in Taiwan were included in 
the study. The number of discharged patients and hospi-
talization patient-days, episodes of nosocomial infection 
and BSI, and average length of hospital stay are shown in 
Table. Due to the differing availability of complete infec-
tion surveillance data from the 11 hospitals, we recorded 
data regarding the rate of BSI per 1,000 patient-days from 
1999 to 2006 in Hospital A, from 1993 to 2006 in Hospital 
B, from 2000 to 2006 in Hospital C, from 2002 to 2006 in 
Hospital D, from 1998 to 2006 in Hospital E, from 2001 
to 2006 in Hospital F, from 1997 to 2006 in Hospital G, 
from 1994 to 2006 in Hospital H, from 1993 to 2005 in 
Hospital I, from 1994 to 2006 in Hospital J, and from 
2002 to 2006 in Hospital K. All 11 hospitals are teaching 
hospitals. Hospitals H and I are located in southern 
Taiwan. Hospital J is located in eastern Taiwan. The other 
hospitals are located in northern Taiwan. All hospitals are 
general hospitals except Hospital C, which is a cancer center 
that serves mainly hemato-oncological patients. Seven of 
the 11 hospitals are tertiary referral medical centers. 
Definition of BSI
The HAI and BSI were defined according to the surveil-
lance guidelines published by the Center of Disease 
Control (CDC) in Taiwan, which were modified from the 
NHSN documents from the CDC in the United States. 
The definition of BSI included laboratory-confirmed BSI 
and clinical sepsis. Laboratory-confirmed BSI should 
CONCLUSION: The overall incidence rate of S. aureus bacteremia in the 11 major hospitals studied had 
decreased over the last decade, though the difference was not statistically significant. However, the rate of 
Candida fungemia and A. baumannii bacteremia had increased significantly.
KEYWORDS: bacteremia, Candida albicans, fungemia, nosocomial, Taiwan
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Table. Density of incidence of healthcare-associated infections and healthcare-associated bloodstream infections in 11 hospitals
 Hospital 
Overall HAI
 
Healthcare-associated BSI
 capacity  
  Patient-admission Overall HAI HAI episodes/ Healthcare-associated BSI episodes/ 
Average
Hospital Year
 day (person-days) episodes 1,000 patient-days BSI episodes 1,000 patient-days 
LOS
A 1999 566,165 2,785 4.90 949 1.68 8.88
 2000 585,979 3,337 5.70 1,311 2.24 8.44
 2001 592,484 3,538 5.97 1,352 2.30 8.21
 2002 631,933 3,584 5.67 1,421 2.25 8.08
 2003 591,217 3,669 6.21 1,517 2.57 8.45
 2004 678,838 4,150 6.11 1,649 2.43 8.40
 2005 684,984 4,128 6.03 1,567 2.29 7.91
 2006 668,355 3,920 5.90 1,507 2.25 7.56
B 1993 191,895 574 2.99 139 0.72 8.74
 1994 221,998 789 3.60 232 1.05 8.03
 1995 228,453 947 4.15 246 1.08 7.30
 1996 220,273 967 4.39 304 1.40 6.98
 1997 219,253 868 3.96 280 1.28 6.61
 1998 217,404 904 4.16 252 1.16 6.75
 1999 217,478 917 4.22 258 1.19 6.78
 2000 221,435 906 4.09 264 1.19 6.86
 2001 211,055 834 3.95 247 1.17 7.06
 2002 211,725 897 4.24 276 1.30 6.96
 2003 198,643 861 4.33 284 1.43 6.63
 2004 211,553 883 4.17 273 1.29 7.16
 2005 207,639 872 4.20 282 1.36 7.37
 2006 209,232 949 4.50 289 1.38 7.22
C 2000 51,999 196 3.77 85 1.63 5.73
 2001 57,045 204 3.58 84 1.47 5.40
 2002 57,622 247 4.29 87 1.51 5.00
 2003 58,675 250 4.26 69 1.18 4.92
 2004 60,915 279 4.58 83 1.36 4.55
 2005 57,589 281 4.88 63 1.09 4.16
 2006 56,919 272 4.78 66 1.16 4.24
D 2002 184,026 609 3.31 144 0.78 7.20
 2003 246,510 987 4.00 194 0.79 8.13
 2004 281,234 1,085 3.86 219 0.78 7.93
 2005 285,011 1,046 3.67 337 1.18 7.66
 2006 282,300 917 3.25 324 1.15 7.47
E 1998 87,624 338 3.86 104 1.19 7.19
 1999 118,842 471 3.96 104 0.88 6.68
 2000 122,259 337 2.76 91 0.74 6.10
 2001 125,490 345 2.75 91 0.73 6.10
 2002 125,473 463 4.00 124 0.99 6.28
 2003 100,296 289 2.88 48 0.48 4.10
 2004 115,225 375 3.25 67 0.58 6.13
 2005 110,711 404 3.65 82 0.74 6.04
 2006 106,506 351 3.30 57 0.54 6.17
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(Contd)
Table. (Contd)
 Hospital 
Overall HAI
 
Healthcare-associated BSI
 capacity  
  Patient-admission Overall HAI HAI episodes/ Healthcare-associated BSI episodes/ 
Average
Hospital Year
 day (person-days) episodes 1,000 patient-days BSI episodes 1,000 patient-days 
LOS
F 2001 399,956 1,417 3.54 371 0.93  8.48
 2002 430,514 1,545 3.60 418 0.97  7.64
 2003 376,682 1,423 3.80 405 1.08  7.32
 2004 440,305 1,605 3.65 433 0.98  7.06
 2005 448,583 1,617 3.60 414 0.92  7.56
 2006 455,849 1,706 3.74 505 1.11  7.55
G 1997 772,761 3,099 4.00 707 0.92 11.00
 1998 784,979 2,895 3.69 690 0.88 10.60
 1999 796,251 3,130 3.93 738 0.93 10.00
 2000 804,864 3,074 3.82 772 0.96  9.62
 2001 789,113 2,877 3.65 722 0.92  9.30
 2002 787,288 2,837 3.60 670 0.85  9.00
 2003 723,822 2,886 4.00 812 1.12  9.67
 2004 805,937 3,054 3.79 860 1.10  9.61
 2005 798,127 3,101 3.89 965 1.21  9.00
 2006 796,519 2,969 3.73 816 1.02  9.30
H 1994 269,793 1,050 3.89 263 0.98  9.10
 1995 298,444 1,136 3.81 255 0.85  8.83
 1996 320,014 1,095 3.42 265 0.83  9.81
 1997 325,258 885 2.72 207 0.64  9.53
 1998 342,324 823 2.40 198 0.58  8.58
 1999 353,131 876 2.48 236 0.67  8.40
 2000 354,378 670 1.89 212 0.60  8.29
 2001 358,734 991 2.76 280 0.78  8.03
 2002 364,431 1,505 4.13 500 1.37  7.93
 2003 316,993 1,417 4.47 464 1.46  7.32
 2004 353,715 1,382 3.91 461 1.30  7.88
 2005 352,822 1,932 5.48 494 1.40  7.52
 2006 346,245 1,590 4.59 436 1.26  8.00
I 1992 189,170 723 3.82 219 1.16  9.43
 1993 197,879 839 4.24 288 1.46  9.07
 1994 207,259 912 4.40 369 1.78  8.66
 1995 212,477 917 4.32 379 1.78  9.27
 1996 214,207 934 4.4 331 1.55  9.23
 1997 246,626 967 3.92 347 1.41 10.40
 1998 263,304 1,032 3.92 379 1.44 10.20
 1999 268,341 1,279 4.77 458 1.71  7.70
 2000 282,926 1,317 4.65 486 1.72  7.61
 2001 278,558 1,416 5.08 531 1.91  7.31
 2002 291,660 1,370 4.70 509 1.75  7.10
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 2003 278,339 1,273 4.57 601 2.16  7.12
 2004 295,228 933 3.16 433 1.50  7.25
 2005 292,128 874 2.99 508 1.74  6.75
J 1994 265,091 878 3.31 121 0.46 11.00
 1995 241,894 945 3.91 125 0.52  9.45
 1996 252,676 1,038 4.11 181 0.72  9.06
 1997 247,662 931 3.76 153 0.62  8.57
 1998 258,754 1,001 3.87 167 0.65  8.17
 1999 270,649 951 3.51 150 0.55  8.00
 2000 263,475 947 3.59 165 0.63  8.06
 2001 246,069 890 3.62 189 0.77  7.48
 2002 271,938 971 3.57 199 0.73  7.51
 2003 254,316 946 3.72 267 1.05  7.44
 2004 304,831 971 3.19 313 1.03  8.47
 2005 267,608 888 3.32 287 1.07  7.64
 2006 271,965 964 3.54 319 1.17  7.19
K 2002 146,872 742 5.05 107 0.73  6.17
 2003 129,104 382 2.96 30 0.23  6.31
 2004 158,140 533 3.37 70 0.44  6.32
 2005 134,420 416 3.09 47 0.35  6.54
 2006 135,903 733 5.39 86 0.63  6.45
HAI = Healthcare-associated infections; BSI = bloodstream infections; LOS = length of stay.
Table. (Contd)
 Hospital 
Overall HAI
 
Healthcare-associated BSI
 capacity  
  Patient-admission Overall HAI HAI episodes/ Healthcare-associated BSI episodes/ 
Average
Hospital Year
 day (person-days) episodes 1,000 patient-days BSI episodes 1,000 patient-days 
LOS
meet at least one of the following criteria: (1) the patient 
has a recognized pathogen cultured from at least one set 
of blood cultures, which was not related to an infection at 
another site; (2) the patient has at least one of the follow-
ing signs or symptoms: fever (> 38°C), chills, or hypoten-
sion (systolic blood pressure > 90 mmHg), and a common 
skin contaminant [e.g. diphtheroids (Corynebacterium 
spp.), Bacillus spp. (not B. anthracis), Propionbacterium spp., 
coagulase-negative staphylococci (including S. epidermidis), 
viridans group Streptococci, Aerococcus spp., or Micrococcus 
spp.)] is cultured from two or more blood cultures drawn 
on separate occasions; (3) a patient less than 1 year of age 
has at least one of the following signs or symptoms: fever 
(anal body temperature > 38°C), hypothermia (anal tem-
perature < 36°C), apnea, and bradycardia and the signs or 
symptoms and positive laboratory results are not 
related to an infection at another site. A common skin 
contaminant is cultured from two or more blood cultures 
drawn on separate occasions.
Data collection
Data obtained from the 11 hospitals included in this study 
covered variable time periods. HAI were diagnosed accord-
ing to the aforementioned definitions and the United 
States CDC guidelines. Data were collected by infection 
control nurses in each hospital. A structured form was sent 
to the hospitals to record information regarding overall pa-
tient discharge numbers, total patient-hospitalization days 
during the study period, the overall number of HAI and 
BSIs, and the number of specific pathogens (Staphylococcus 
aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, 
and Candida species). For the Candida spp., the incidence 
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and relative percentages of the different species were also 
recorded. Data were analyzed using the χ2 test and a p 
value of < 0.05 indicated statistical significance.
Results
More than 20,000 patients per year were discharged from 
each individual hospital, except for Hospitals C and E. 
The other nine hospitals had one year admissions ranging 
from 20,061 (Hospital I, 1992) to 88,444 (Hospital A, 
2006). The average number of patient discharges during 
the study period were as follows: 76,173.9 for Hospital A; 
29,931.8 for Hospital B; 11,963 for Hospital C; 33,296.4 
for Hospital D; 18,815 for Hospital E; 56,168.5 for 
Hospital F; 80,889.9 for Hospital G; 40,308.2 for Hospital 
H; 31,123.4 for Hospital I; 32,010.3 for Hospital J; and 
22,185.2 for Hospital K. The average length of stay ranged 
from 4.1 days (Hospital E, 2003) to 11.0 days (Hospital J, 
1994), with a mean value of 8.1 days. The patient-admission 
days ranged from 51,999 patient-days (Hospital C, 2000) 
to 805,937 patient-days (Hospital G, 2004). In 1992, only 
one hospital (Hospital I) reported its overall HAI rates and 
BSI rates. Thus, it was excluded from further analysis due 
to possible bias. During the 14-year study period, a total 
of 4,080,698 discharged patients were recorded, and the 
patient-admission days numbered 33,087,563.
As shown in Table, the overall number of healthcare-
associated episodes varied between different hospitals 
and different time periods. The overall number of HAI 
was 135,525 from 1993 to 2006, and the rate of HAI per 
100 discharged patients was 3.32. The average number of 
HAI per 1,000 patient-days was 4.10. However, the annual 
density of HAI (HAI per 1,000 patient-days) ranged from 
as low as 1.89 per 1,000 patient-days (Hospital H, 2000) to 
as high as 6.21 per 1,000 patient-days (Hospital A, 2003). 
During the 14-year study period, the density of HAI ranged 
from 3 to 5 per 1,000 patient-days in most of the hospitals 
studied (Figure 1). Data recording the incidence of HAI was 
available from 1997 for Hospital A, which ranked highest 
throughout the study period.
Among all the HAI, 40,805 episodes of BSI were 
recorded according the CDC criteria. The number of 
BSI per 100 discharged patients was 1.0, while the BSI per 
1,000 patient-days was 1.23. The annual density of BSI 
incidence varied from 0.23 to 2.56 per 1,000 patient-days, 
but the incidence in most hospitals were less than 2 per 
1,000 patient-days (except in Hospital A and Hospital C). 
BSI accounted for 8–43% of all HAI from 1993 to 2006.
Of the organisms that caused healthcare-associated 
BSI, S. aureus was the most common. The annual inci-
dence was 0.01 BSI per 1,000 patient-days to 0.88 BSI per 
1,000 patient-days (Figure 2A). The annual incidence of 
S. aureus BSI in Hospital C was the highest, ranging from 
0.46 to 0.88 per 1,000 patient-days. The annual incidence 
of S. aureus BSI was less than 0.4 per 1,000 patient-days in 
all other hospitals (except Hospital A during 2000). 
Regarding P. aeruginosa BSI, the incidence was lower than 
that of S. aureus (< 0.2 per 1,000 patient-days; except for 
Hospital C). The annual incidence of P. aeruginosa BSI in 
the other hospitals remained stationary in 1993–2006 
(Figure 2B). The incidence of A. baumannii BSI ranged be-
tween 0–0.46 per 1,000 patient-days. Most hospitals, ex-
cept Hospitals A and C, had an A. baumannii BSI incidence 
of less than 0.25 per 1,000 patient-days (Figure 2C). 
The overall results for S. aureus, P. aeruginosa, A. bau-
mannii, and Candida spp.-related BSI are shown in Figure 3. 
The trends were analyzed from 1999 to 2006. The inci-
dence of S. aureus bacteremia decreased, but the p value 
was 0.053, which barely reached significance. The inci-
dence of Candida spp.- (p < 0.001) and A. baumannii- 
(p = 0.030) related BSI increased significantly, whereas the 
incidence of P. aeruginosa BSI was unchanged (p = 0.431). 
Of the different Candida species causing healthcare-
associated BSI, Candida albicans was the most predominant 
(Figure 4). The incidence of Candida-related BSI varied 
widely between the hospitals, and C. albicans accounted for 
50–80% of all Candida infections. The percentage of C. albicans-
related BSI was unchanged during the study period. Candida 
tropicalis, Candida parapsilosis, and C. glabrata were the second, 
third, and fourth most commonly isolated Candida spp. in 
healthcare-associated BSI (Figure 4).
Discussion
The characteristics of the nosocomial infections varied 
from hospital to hospital and from region to region. Thus, 
regular surveillance is important to understand the patho-
gens causing nosocomial infections. National surveillance 
programs were initiated in many countries by the 
International Nosocomial Infection Control Consortium,9 
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Figure 1. Density of (A) overall healthcare-associated infections and (B) bloodstream infections from 1993 to 2006.
including the Unites States,3,5,18 Germany,12,19 Spain,20 
England,14 and France,13 as well as in some developing 
countries in Latin America, Europe, Asia, and Africa and 
many other countries. The CDC in Taiwan also estab-
lished guidelines for the surveillance of HAI, which were 
modified from the US CDC guidelines. However, few pub-
lished studies regarding trends in healthcare-associated 
BSI in Taiwan are available.
Chang et al reported epidemiological surveillance re-
sults for nosocomial infections from a single hospital in 
Taiwan in 1990.16 Surgical wound infections were the 
most common HAI, while BSI ranked fourth. The most 
frequently isolated pathogen was Escherichia coli in the 
early years but shifted to P. aeruginosa in later years. Gram-
negative aerobic pathogens were the most frequently iso-
lated organisms from 1981 to 1989. An increased 
incidence of fungal infection was also mentioned, which 
increased from 1.8% to 7.7% of all HAI. However, this re-
port did not specify the relative proportion of causative 
organisms or the trends in healthcare-associated BSI. In 
2002, Tseng et al investigated the nosocomial BSI in a 
single neonatal intensive care unit (ICU) in a university 
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hospital reported their experience of nosocomial BSIs 
between 1996–2003.17 The overall incidence was 1.79 per 1,000 
patient-days. The five leading causative organisms were co-
agulase-negative Staphylococci (16%), S. aureus (13%), Candida 
spp. (10%), A. baumannii (8%) and E. coli (8%). Gram-negative 
bacilli were the predominant pathogens related to health-
care-associated BSI during the 8-year study period. Because 
of the multi-center design, not all bacterial species were re-
ported in this study. Thus, the percentage of each causative 
organism cannot be calculated exactly. Coagulase-negative 
Staphylococci were the most predominant strains in Hospital 
I during the study period, while S. aureus predominated in 
most other hospitals during the study period. 
The overall incidence of BSI was 1.23 per 1,000 patient-
days in our study, which was similar to the incidence of 
1.79 per 1,000 patient-days reported by Wu at al17 and 
lower than the 4.4 per 1,000 patient days by Tseng et al.21 
Our study subjects comprised all inpatients hospitalized in 
general wards and ICU, which may explain the difference. 
The higher rate of healthcare-associated BSI in neonatal 
ICUs is not surprising. Another surveillance of nosocomial 
infections in a neonatal ICU in Taiwan disclosed 22 BSI 
and 38 clinical sepsis cases over 6,448 patient-days (8.72 
episodes per 1,000 patient days).22 A Dutch neonatal ICU 
surveillance report showed even higher results (14.9 epi-
sodes per 1,000 patient-days).23 Thus, our results were not 
limited to a single unit in a hospital but comprised a gen-
eral surveillance of all inpatient wards and ICUs. Wu et al17 
also disclosed similar results to those of our study. We ex-
panded the surveillance period and invited 11 hospitals 
from different regions to participate, and so our results are 
more representative of the current conditions in Taiwan. 
All 11 hospitals in our study are teaching hospitals 
with different sized ICUs. Higher catheter utilization 
rates and HAI rates had been observed in the combined 
medical-surgical ICUs in teaching hospitals as compared 
with non-teaching hospitals.24 Catheter utilization itself 
is also an important risk factor for HAI.25 Thus, the ob-
served incidence may be an overestimate if applied to 
non-teaching hospitals. The NNIS5 and the NHSN3,4 in 
the USA also differentiate medical-surgical ICUs in major 
teaching hospital from all other hospitals. Higher rates of 
catheter utilization and central line-associated BSI were 
observed in the medical-surgical ICUs of major teaching 
hospitals than in other hospitals. The NHSN surveillance 
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among all Candida associated bloodstream infections.
hospital.21 The overall infection rate was 4.4 episodes per 
1,000 patient-days. In agreement with our results, the 
most common causative pathogen was S. aureus, which ac-
counted for 18.5% of all BSI. E. coli and P. aeruginosa ac-
counted for only 9.6% and 8.1% of all BSIs, respectively, 
and ranked fourth and fifth. Different hospital settings, 
study periods, and target populations may explain the dif-
ferences between the two studies. Another university 
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report published a summary of data obtained from June 
2007 to November 2008. The surveillance data from 2006 
was also included in the latter report. Summing up all the 
data from all ICUs and wards obtained during 2006, 
a total of 2,681 cases of central line-associated BSI were 
recorded during 1,912,392 patient-days (1.40 per 1,000 
patient-days).4 In another, 6,059 episodes were noted, 
while the summation of patient-days from all ICUs and 
wards was 6,161,064 (0.98 episodes per 1,000 patient-
days).3 This rapid decrease in the overall rates may not 
reflect a true trend of decreasing BSI rates, but a reflection 
of the different compositions of the reporting hospitals. 
A 3.5-fold increase in mixed medical-surgical ICUs in 
non-major teaching hospitals was noted, which were 
associated with a lower risk of HAI. In our study, we in-
cluded all cases of nosocomial BSI rather than central 
catheter-associated BSI only. The incidence in our study 
was 1.23 per 1,000 patient-days, which was comparable to 
the incidence of 1.40 reported in the 2007 NHSN report, 
and slightly higher than the result of 0.98 published in 
the 2008 report. Since we did not record the usage of cen-
tral catheters, or device-days, in our study, we cannot eval-
uate the rate of central line-associated BSI exactly, but it is 
expected to be lower than the overall rate of healthcare-
associated BSI because not every inpatient requires a cen-
tral line. Higher rates of BSI were reported by an NNIS 
surveillance report and the NICC,5,7,8 which was con-
ducted in 98 ICUs in 18 developing countries on four con-
tinents; though both reported catheter-associated BSI 
from ICUs only. The incidence in developing countries 
was three to five times higher than that reported by the 
NNIS. The lack of legal frameworks, limited national in-
fection control guidelines, poor hand hygiene, low nurse-
to-patient ratios and overcrowded units may all contribute 
to the high HAI rates in developing countries.26–28 The 
NNIS report issued in October 2004 was based on data 
collected from January 1992 through June 2004, similar to 
our report. However, the report primarily focused on cen-
tral line-associated BSI rates (events per 1,000 central line-
days) in different types of ICU. Thus, we cannot compare 
our BSI rate with the NNIS 2004 report directly. 
Wisplinghoff et al reported the result of the Surveillance 
and Control of Pathogens of Epidemiological Importance, 
a nationwide surveillance in the USA, and analyzed 24,179 
cases of nosocomial BSI.18 The incidence was 60 cases 
per 10,000 hospital admissions, without any significant 
changes between 1995–2002, and the results were not 
limited to patients in ICUs or central line-associated 
infections. In our study, a total of 81,610 BSI were noted 
in 8,161,396 discharged patients, which translates into 
10.0 episodes per 1,000 patients, slightly higher than the 
results from the Surveillance and Control of Pathogens of 
Epidemiological Importance study. A longer period of 
continuous follow-up and the inclusion of non-teaching 
hospitals may be needed in further studies.
Of the 11 hospitals enrolled in our study, Hospital A 
had the highest rate of BSI (2.25 episodes per 1,000 pa-
tient-days), followed by Hospital I (1.66 episodes per 
1,000 patient-days) and Hospital C (1.34 episodes per 
1,000 patient-days). Hospital A and Hospital I are both 
major teaching hospitals according to the NHSN defini-
tion,3 while Hospital C is a hemato-oncologic cancer 
center. Higher device-utilization rates and higher infec-
tion rates had been demonstrated in major teaching hos-
pitals.24 Also, both Hospital A and Hospital I are 
university hospitals, so more staff rotations, clerkships, 
and internship training is expected. A previous study in a 
Spanish surgical ICU demonstrated unusual high rates of 
ventilator-associated pneumonia in February and BSI in 
May, which may relate to staff vacations and rotations.29 
Other studies also show an increased risk of 2.75-fold 
when patients were cared by substitute staff during vaca-
tions.30,31 The price of staff training and the risk of 
healthcare infections should be balanced when consider-
ing the issue of patient safety. Both hospitals are tertiary 
referral centers, so increased patient disease severity may 
have partially contributed to this. The average length of 
stay in Hospital A and Hospital I was 8.24 days and 8.36 
days, respectively, while the average length of stay in our 
study was 8.1 days. However, both Hospital G (9.75 days) 
and Hospital H (8.40 days) had higher inpatient days but 
lower BSI rates. Further analysis of patient severity such 
as APACHE II scores, staff rotation rates, and catheter uti-
lization rates should be considered in future studies to 
clarify this issue. The higher BSI rate in Hospital C is not 
surprising, since hematology/oncology wards and bone 
marrow transplant units are associated with a higher 
risk of nosocomial infections.3 A total of 110 central line-
associated BSI developed over 42,459 patient-days in 
bone marrow transplant units (2.59 episodes per 1,000 
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patient-days), while another 44 episodes during 69,487 
patient-days were recorded in hematology/oncology 
wards (0.63 episodes per 1,000 patient-days) between 
2006–2007 as reported by the NHSN.3
A recent report by Burton et al showed a decreasing 
trend in the incidence of MRSA central line-associated 
BSI in ICUs in the United States.32 In all the evaluated 
ICUs, a significant decline was observed between 2001–
2007, except in pediatric units. Both the overall propor-
tion of S. aureus related central line BSI and the overall 
incidence of MRSA showed similar trends. Further analy-
sis showed that the trends for MRSA central line-associ-
ated BSI increased until 2001, but declined significantly 
thereafter. The overall rate of MSSA central line-associ-
ated BSI steadily decreased from 1997 to 2007. In Taiwan, 
the incidence of S. aureus-related bacteremia reached a 
plateau in 2000 and decreased thereafter (Figure 3). Due 
to the dynamic nature of the NNIS/NHSN reports, less 
than 6% of ICUs participated during the 11-year-study by 
Burton et al.33 Between 1999 and 2006, the results of our 
study showed a decreasing trend in S. aureus BSI in all in-
patients, though the p value was not significant. No stud-
ies regarding the long-term trends in the incidence of 
nosocomial S. aureus bacteremia have been published re-
cently. Although our observations support the notion 
that the incidence of healthcare-associated S. aureus BSI is 
decreasing, this should be interpreted cautiously since the 
disease burden of MRSA remains high.34,35 Further analy-
sis of data from different regions, different ICU types or 
wards, and the relationship between current infection 
control measurements is needed. Also, a longer follow-up 
period and a higher number of enrolled institutes may be 
needed to determine if the incidence of S. aureus bactere-
mia is really decreasing. 
Compared with S. aureus BSI, the overall incidence of 
Candidemia is rising. However, the incidence varied from 
hospital to hospital. The highest incidence was observed 
in hemato-oncologic centers, which might reflect their 
patient characteristics and more prominent catheter use. 
A prospective surveillance conducted in 11 medical cent-
ers in Brazil from March 2003 to December 2004 reported 
that the overall incidence of Candida spp.-related and 
C. albicans-related fungemia was 0.37 and 0.15 episodes 
per 1,000 patient-days, respectively.36 The incidence in 
our study was 0.15 and 0.10 per 1,000 patient-days, 
respectively. If we calculated the incidence rate per every 
1,000 discharged patients, it would be 1.20 episodes per 
1,000. Hospital C reported the highest rates of fungal-
related BSI, reaching a peak of 0.61/1,000 patient-days in 
2003 and 2006, which may be related to its patient charac-
teristics. Previous surveillance in Taiwan disclosed a high 
incidence rate of 2.88 cases per 1,000 discharges at a 
single university hospital,37 which was higher than other 
reports worldwide (e.g. 0.28–0.96 per 1,000 admissions in 
the United States,18,38–40 0.45 per 1,000 admissions in 
Canada,41 0.20–0.38 per 1,000 admissions in Europe,42 
and 0.76–0.81 per 1,000 admissions in Spain43,44). The 
relatively high incidence of nosocomial fungal BSI may be 
multi-factorial. First, the predominance of teaching hos-
pitals in our survey may be an origin of bias, due to higher 
disease severity and longer periods of hospitalization. 
Second, the lack of previous general surveillance may 
make clinicians unaware of the high incidence in Taiwan 
and so they do not pay attention to the threat of rising 
nosocomial fungal infections. However, since our overall 
rates of HAI are comparable with surveillance results from 
the United States, the high rate of fungal BSI should de-
mand our attention. As for the different species contribut-
ing to Candidemia, the relative proportions of C. albicans, 
C. parapsilosis, C. tropicalis, and C. glabrata were stationary dur-
ing the study period. C. albicans was the most common or-
ganism isolated, accounting for about 50% of cases. Some 
studies report an increased incidence of other non-albicans 
Candida spp. over the past decade, but this was not observed 
in our study.45–47 The irregular use of fluconazole as a pro-
phylactic agent in our country may be the reason for this 
stationary trend.48 Similar results have also been demon-
strated in earlier single-center studies in Taiwan.48
This study has several limitations. First, since we have 
conducted the first inter-hospital surveillance in Taiwan, 
data collection in during the early years may be incom-
plete, and only teaching hospitals were included in this 
study. The lack of consensus in the recording of HAI by 
infection control practitioners in the different hospitals 
made interpretation more difficult. Some hospitals re-
corded the number of infection episodes per 1,000 admit-
ted patients during earlier years, but most hospitals 
shifted to recording the number of episodes per 1,000 
patient-days. A uniform record form may be needed to 
ensure the comprehensiveness and consistency of data. 
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Second, we only collect data on the three most common 
bacterial pathogens causing BSI; thus, we could not 
demonstrate the relative proportion of each pathogen. 
Instead, we reported the absolute incidence and trends for 
some clinically important organisms. Third, there was no 
verification of the inclusion of HAI in each hospital. Some 
hospitals may have under-reported the incidence of HAI 
or BSI. For example, some hospitals reported no cases of 
fungal BSI from 1993 to 1996, which is unusual for a gen-
eral hospital with a service capacity of 21,947 to 31,542 
patients per year. Further verification may be needed in 
follow-up surveillance programs to ensure the quality of 
inclusion or exclusion. Fourth, the association of current 
trends and the use of antimicrobial agents should also be 
considered, since the use of antimicrobial agents may 
shift the ecology of bacterial and fungal infections. 
Moreover, this report could not evaluate the relationship 
between infection control methods and trends because of 
the heterogeneity of our study populations. 
In conclusion, this is the first inter-hospital surveil-
lance of healthcare-associated BSI in Taiwan. The results 
show a higher proportion of fungal BSI compared with 
surveillance reports in the United States. In 11 major hos-
pitals in Taiwan, the overall incidence of S. aureus bacter-
emia decreased over the last decade, although the result 
was not statistically significant. However, the rate of 
Candida fungemia and A. baumannii bacteremia in-
creased significantly. The rate of Pseudomonas aerugi-
nosa-related BSI remained stationary during the study 
period. Further follow-up surveillance is required to mon-
itor these trends.
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